These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 14520484)

  • 1. High plasma level of asymmetric dimethylarginine in patients with acutely exacerbated congestive heart failure: role in reduction of plasma nitric oxide level.
    Saitoh M; Osanai T; Kamada T; Matsunaga T; Ishizaka H; Hanada H; Okumura K
    Heart Vessels; 2003 Sep; 18(4):177-82. PubMed ID: 14520484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased endogenous nitric oxide synthase inhibitor in patients with congestive heart failure.
    Usui M; Matsuoka H; Miyazaki H; Ueda S; Okuda S; Imaizumi T
    Life Sci; 1998; 62(26):2425-30. PubMed ID: 9651109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelin stimulates an endogenous nitric oxide synthase inhibitor, asymmetric dimethylarginine, in experimental heart failure.
    Ohnishi M; Wada A; Tsutamoto T; Fujii M; Matsumoto T; Yamamoto T; Takayama T; Wang X; Kinoshita M
    Clin Sci (Lond); 2002 Aug; 103 Suppl 48():241S-244S. PubMed ID: 12193095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevation of an endogenous inhibitor of nitric oxide synthesis in experimental congestive heart failure.
    Feng Q; Lu X; Fortin AJ; Pettersson A; Hedner T; Kline RL; Arnold JM
    Cardiovasc Res; 1998 Mar; 37(3):667-75. PubMed ID: 9659450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased (E)-4-hydroxy-2-nonenal and asymmetric dimethylarginine concentrations and decreased nitric oxide concentrations in the plasma of patients with major depression.
    Selley ML
    J Affect Disord; 2004 Jun; 80(2-3):249-56. PubMed ID: 15207938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intensive treatment of risk factors in patients with type-2 diabetes mellitus is associated with improvement of endothelial function coupled with a reduction in the levels of plasma asymmetric dimethylarginine and endogenous inhibitor of nitric oxide synthase.
    Yasuda S; Miyazaki S; Kanda M; Goto Y; Suzuki M; Harano Y; Nonogi H
    Eur Heart J; 2006 May; 27(10):1159-65. PubMed ID: 16627554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma concentration of asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, is elevated in hyperthyroid patients.
    Hermenegildo C; Medina P; Peiró M; Segarra G; Vila JM; Ortega J; Lluch S
    J Clin Endocrinol Metab; 2002 Dec; 87(12):5636-40. PubMed ID: 12466365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of simvastatin on endothelium-dependent vaso-relaxation and endogenous nitric oxide synthase inhibitor.
    Jiang JL; Jiang DJ; Tang YH; Li NS; Deng HW; Li YJ
    Acta Pharmacol Sin; 2004 Jul; 25(7):893-901. PubMed ID: 15210062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma concentrations of nitric oxide and asymmetric dimethylarginine in human alcoholic cirrhosis.
    Lluch P; Torondel B; Medina P; Segarra G; Del Olmo JA; Serra MA; Rodrigo JM
    J Hepatol; 2004 Jul; 41(1):55-9. PubMed ID: 15246208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma asymmetric dimethylarginine, symmetric dimethylarginine, l-arginine, and nitrite/nitrate concentrations in cats with chronic kidney disease and hypertension.
    Jepson RE; Syme HM; Vallance C; Elliott J
    J Vet Intern Med; 2008; 22(2):317-24. PubMed ID: 18371026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased concentrations of homocysteine and asymmetric dimethylarginine and decreased concentrations of nitric oxide in the plasma of patients with Alzheimer's disease.
    Selley ML
    Neurobiol Aging; 2003 Nov; 24(7):903-7. PubMed ID: 12928048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Asymmetric dimethylarginine and nitric oxide levels as signs of endothelial dysfunction in Behcet's disease.
    Sahin M; Arslan C; Naziroglu M; Tunc SE; Demirci M; Sutcu R; Yilmaz N
    Ann Clin Lab Sci; 2006; 36(4):449-54. PubMed ID: 17127734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of asymmetric dimethylarginine (ADMA) using a novel ELISA assay.
    Schulze F; Wesemann R; Schwedhelm E; Sydow K; Albsmeier J; Cooke JP; Böger RH
    Clin Chem Lab Med; 2004; 42(12):1377-83. PubMed ID: 15576299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Folic acid treatment reduces elevated plasma levels of asymmetric dimethylarginine in hyperhomocysteinaemic subjects.
    Holven KB; Haugstad TS; Holm T; Aukrust P; Ose L; Nenseter MS
    Br J Nutr; 2003 Mar; 89(3):359-63. PubMed ID: 12628031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Asymmetric dimethylarginine is increased in chronic thromboembolic pulmonary hypertension.
    Skoro-Sajer N; Mittermayer F; Panzenboeck A; Bonderman D; Sadushi R; Hitsch R; Jakowitsch J; Klepetko W; Kneussl MP; Wolzt M; Lang IM
    Am J Respir Crit Care Med; 2007 Dec; 176(11):1154-60. PubMed ID: 17872491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Asymmetric dimethylarginine plasma concentrations and L-arginine/asymmetric dimethylarginine ratio in patients with slow coronary flow.
    Selcuk MT; Selcuk H; Temizhan A; Maden O; Ulupinar H; Baysal E; Ozeke O; Sasmaz A
    Coron Artery Dis; 2007 Nov; 18(7):545-51. PubMed ID: 17925608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated plasma concentrations of the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine predict adverse events in patients undergoing noncardiac surgery.
    Maas R; Dentz L; Schwedhelm E; Thoms W; Kuss O; Hiltmeyer N; Haddad M; Klöss T; Standl T; Böger RH
    Crit Care Med; 2007 Aug; 35(8):1876-81. PubMed ID: 17581491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma asymmetric dimethylarginine (ADMA), nitrate and the indices of low-density lipoprotein oxidation.
    Päivä H; Laakso J; Ruokonen I; Luomala M; Saarela M; Solakivi T; Metso S; Nikkilä M; Wuolijoki E; Laaksonen R; Lehtimäki T
    Clin Chim Acta; 2006 Sep; 371(1-2):97-101. PubMed ID: 16626676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of atorvastatin on plasma levels of asymmetric dimethylarginine in patients with non-ischaemic heart failure.
    Young JM; Strey CH; George PM; Florkowski CM; Sies CW; Frampton CM; Scott RS
    Eur J Heart Fail; 2008 May; 10(5):463-6. PubMed ID: 18430606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Relationship between serum asymmetric dimethylarginine and blood pressure in patients with chronic renal failure].
    Zhang WR; Tao LJ; Chen BM
    Hunan Yi Ke Da Xue Xue Bao; 2002 Apr; 27(2):133-4. PubMed ID: 12575339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.